Alnylam Pharmaceuticals
ALNY
#537
Rank
S$57.20 B
Marketcap
S$433.01
Share price
0.68%
Change (1 day)
15.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company